• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

情绪识别处理作为晚年抑郁症患者对8周西酞普兰治疗反应的早期预测指标。

Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression.

作者信息

Shiroma Paulo R, Thuras Paul, Johns Brian, Lim Kelvin O

机构信息

Mental Health Service Line, Minneapolis VA Medical Center, Minneapolis, MN, USA; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.

出版信息

Int J Geriatr Psychiatry. 2014 Nov;29(11):1132-9. doi: 10.1002/gps.4104. Epub 2014 Apr 4.

DOI:10.1002/gps.4104
PMID:24706294
Abstract

BACKGROUND

In subjects with depression, exposure to antidepressants improves recognition of positive emotions. This phenomenon, which occurs early in the course of treatment, has been proposed as the initial step in the mechanism of action to subsequent therapeutic effects of antidepressants. To this date, it has not been well examined among older depressed patients.

METHOD

Older subjects with non-psychotic major depressive disorder were treated with citalopram in an 8-week open-label study. The main predictor of response and remission was the change in emotion recognition between baseline and day 7. Covariates included executive functions, baseline anxiety level, medical comorbidity, level of subjective stress, serum citalopram level, and level of social support.

RESULTS

Twenty-seven patients were considered for final analysis. Overall, accuracy of emotion recognition significantly improved between baseline (75%) and day 7 (83%) (X(2)  = 34.50, df = 1, p < 0.001). Improvement to identify happy expressions occurred at 25% and 50% intensity with ceiling effect at 0%, 75%, and 100%. Change in emotion processing was marginally significant in predicting antidepressant response at day 56. Multivariate analysis showed that emotion processing is a significant predictor of response and remission when considered along with perceived level of social support.

CONCLUSIONS

Recognition of mildly intense happy expression, which improved early in the course of citalopram treatment, predicts subsequent antidepressant response and remission when considered along with perception of social support. Further studies would be necessary to examine specific neural substrates in the affective network involved in the acute therapeutic action of antidepressant in late-life depression.

摘要

背景

在抑郁症患者中,服用抗抑郁药可改善对积极情绪的识别。这种现象在治疗过程早期出现,被认为是抗抑郁药后续治疗效果作用机制的初始步骤。迄今为止,在老年抑郁症患者中尚未得到充分研究。

方法

在一项为期8周的开放标签研究中,使用西酞普兰治疗患有非精神病性重度抑郁症的老年受试者。反应和缓解的主要预测指标是基线和第7天之间情绪识别的变化。协变量包括执行功能、基线焦虑水平、合并症、主观压力水平、血清西酞普兰水平和社会支持水平。

结果

27例患者纳入最终分析。总体而言,情绪识别准确率在基线时(75%)和第7天(83%)之间显著提高(X(2) = 34.50,自由度 = 1,p < 0.001)。识别快乐表情的改善出现在25%和50%强度时,在0%、75%和100%强度时出现天花板效应。在预测第56天的抗抑郁反应时,情绪处理的变化具有边缘显著性。多变量分析表明,当与感知到的社会支持水平一起考虑时,情绪处理是反应和缓解的显著预测指标。

结论

在西酞普兰治疗过程早期改善的对轻度强烈快乐表情的识别,与社会支持感知一起考虑时,可预测后续抗抑郁反应和缓解。有必要进行进一步研究,以检查参与老年抑郁症抗抑郁药急性治疗作用的情感网络中的特定神经基质。

相似文献

1
Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression.情绪识别处理作为晚年抑郁症患者对8周西酞普兰治疗反应的早期预测指标。
Int J Geriatr Psychiatry. 2014 Nov;29(11):1132-9. doi: 10.1002/gps.4104. Epub 2014 Apr 4.
2
The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.血清素能和去甲肾上腺素能抗抑郁药对抑郁症患者面部情绪加工的影响。
J Affect Disord. 2009 Nov;118(1-3):87-93. doi: 10.1016/j.jad.2009.01.028. Epub 2009 Feb 27.
3
Neural responses to happy facial expressions in major depression following antidepressant treatment.抗抑郁治疗后重度抑郁症患者对快乐面部表情的神经反应。
Am J Psychiatry. 2007 Apr;164(4):599-607. doi: 10.1176/ajp.2007.164.4.599.
4
Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.作为抑郁症患者对选择性5-羟色胺再摄取抑制剂(SSRI)治疗临床反应标志物的情绪加工早期变化。
Transl Psychiatry. 2016 Nov 22;6(11):e957. doi: 10.1038/tp.2016.130.
5
Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.在随机iSPOT-D试验中,杏仁核对情绪面孔的反应性在预测抗抑郁治疗的总体反应和特定药物反应中的作用
Neuropsychopharmacology. 2015 Sep;40(10):2398-408. doi: 10.1038/npp.2015.89. Epub 2015 Mar 31.
6
[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].艾司西酞普兰在治疗重度重度抑郁症方面比西酞普兰更有效。
Encephale. 2004 Mar-Apr;30(2):158-66. doi: 10.1016/s0013-7006(04)95427-9.
7
Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex.预测抑郁症的治疗反应:前扣带皮层的作用。
Int J Neuropsychopharmacol. 2018 Nov 1;21(11):988-996. doi: 10.1093/ijnp/pyy069.
8
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.在选择性5-羟色胺和去甲肾上腺素再摄取抑制后,健康志愿者的积极情感感知和记忆相对于消极情感感知和记忆有所增强。
Am J Psychiatry. 2004 Jul;161(7):1256-63. doi: 10.1176/appi.ajp.161.7.1256.
9
Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation.西酞普兰增强 5-羟色胺神经传递调制中度悲伤面部情绪刺激的情绪表达解码而不影响结构编码:一项事件相关电位(ERP)研究。
J Psychopharmacol. 2010 Aug;24(8):1153-64. doi: 10.1177/0269881108097878. Epub 2008 Oct 2.
10
Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression.锂单药治疗的急性抗抑郁疗效,而不是西酞普兰,取决于抑郁的反复发作。
J Clin Psychopharmacol. 2013 Feb;33(1):38-44. doi: 10.1097/JCP.0b013e31827b9495.

引用本文的文献

1
An open label pilot study of micro expression recognition training as an intervention for low mood.一项关于微表情识别训练作为改善情绪低落干预措施的开放标签试点研究。
Sci Rep. 2025 May 19;15(1):17302. doi: 10.1038/s41598-025-01132-w.
2
Emotional Processing Following Digital Cognitive Behavioral Therapy for Insomnia in People With Depressive Symptoms: A Randomized Clinical Trial.针对有抑郁症状的失眠患者的数字认知行为疗法后的情绪处理:一项随机临床试验。
JAMA Netw Open. 2025 Feb 3;8(2):e2461502. doi: 10.1001/jamanetworkopen.2024.61502.
3
Acute neural effects of the mood stabiliser lamotrigine on emotional processing in healthy volunteers: a randomised control trial.
心境稳定剂拉莫三嗪对健康志愿者情绪处理的急性神经效应:一项随机对照试验。
Transl Psychiatry. 2024 May 27;14(1):211. doi: 10.1038/s41398-024-02944-6.
4
Therapeutic doses of ketamine acutely attenuate the aversive effect of losses during decision-making.治疗剂量的氯胺酮可在决策过程中急性减弱损失带来的厌恶效应。
Elife. 2024 May 3;12:RP87529. doi: 10.7554/eLife.87529.
5
Abnormal ambiguous facial expression recognition in Chinese patients with schizophrenia.精神分裂症患者异常的面部表情识别障碍。
BMC Psychiatry. 2024 Mar 26;24(1):226. doi: 10.1186/s12888-024-05685-4.
6
A critical overview of emotion processing assessment in non-affective and affective psychoses.非情感性和情感性精神病中情绪处理评估的批判性综述。
Epidemiol Psychiatr Sci. 2024 Feb 15;33:e8. doi: 10.1017/S204579602400009X.
7
Boosting Serotonin Increases Information Gathering by Reducing Subjective Cognitive Costs.提高血清素水平可降低主观认知成本,从而增加信息收集。
J Neurosci. 2023 Aug 9;43(32):5848-5855. doi: 10.1523/JNEUROSCI.1416-22.2023. Epub 2023 Jul 31.
8
Mentalising and depression: a mini-review on behavior, neural substrates, and treatment options.心理化与抑郁症:关于行为、神经基础及治疗选择的小型综述
Front Psychiatry. 2023 Jun 15;14:1116306. doi: 10.3389/fpsyt.2023.1116306. eCollection 2023.
9
Facial emotion recognition in patients with depression compared to healthy controls when using human avatars.使用人类化身时,比较抑郁症患者与健康对照者的面部情绪识别。
Sci Rep. 2023 Apr 12;13(1):6007. doi: 10.1038/s41598-023-31277-5.
10
Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation.基于食欲素受体调节的新型精神治疗方法的开发中实验医学方法的应用。
Neurosci Biobehav Rev. 2023 Apr;147:105107. doi: 10.1016/j.neubiorev.2023.105107. Epub 2023 Feb 23.